- Home
- WORX vs SLRX Comparison
WORX vs SLRX Comparison
Compare WORX & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- SLRX
- Stock Information
- Founded
- WORX N/A
- SLRX N/A
- Country
- WORX United States
- SLRX United States
- Employees
- WORX N/A
- SLRX N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- WORX Consumer Discretionary
- SLRX Health Care
- Exchange
- WORX Nasdaq
- SLRX Nasdaq
- Market Cap
- WORX 3.6M
- SLRX 3.6M
- IPO Year
- WORX N/A
- SLRX N/A
- Fundamental
- Price
- WORX $0.29
- SLRX $3.01
- Analyst Decision
- WORX
- SLRX
- Analyst Count
- WORX 0
- SLRX 0
- Target Price
- WORX N/A
- SLRX N/A
- AVG Volume (30 Days)
- WORX 3.1M
- SLRX 151.4K
- Earning Date
- WORX 11-14-2025
- SLRX 11-10-2025
- Dividend Yield
- WORX N/A
- SLRX N/A
- EPS Growth
- WORX N/A
- SLRX N/A
- EPS
- WORX N/A
- SLRX N/A
- Revenue
- WORX $2,838,404.00
- SLRX N/A
- Revenue This Year
- WORX N/A
- SLRX N/A
- Revenue Next Year
- WORX N/A
- SLRX N/A
- P/E Ratio
- WORX N/A
- SLRX N/A
- Revenue Growth
- WORX N/A
- SLRX N/A
- 52 Week Low
- WORX $0.26
- SLRX $3.01
- 52 Week High
- WORX $3.31
- SLRX $108.00
- Technical
- Relative Strength Index (RSI)
- WORX 48.29
- SLRX 34.50
- Support Level
- WORX $0.27
- SLRX $3.55
- Resistance Level
- WORX $0.34
- SLRX $3.97
- Average True Range (ATR)
- WORX 0.03
- SLRX 0.31
- MACD
- WORX -0.00
- SLRX -0.10
- Stochastic Oscillator
- WORX 23.58
- SLRX 0.00
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.